SCHEMBL28003170

SCHEMBL28003170

COc1csc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.47
TP53 P04637 3/20 0.46
MAPT P10636 2/20 0.46
DYRK3 O43781 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
DYRK1A Q13627 1/20 0.45
DYRK2 Q92630 1/20 0.45
DYRK1B Q9Y463 1/20 0.45
ATP4A P20648 2/20 0.44
ATP4B P51164 2/20 0.44
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PIM1 P11309 2/20 0.43
TLR7 Q9NYK1 1/20 0.43
KIF11 P52732 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28003155 0.81 SCN10A (0.49) CYP19A1MAPTKDM4EPIM1
SCHEMBL28003513 0.81 CYP19A1 (0.60) CYP19A1MAPTCDK2KDM4EKMT2A
SCHEMBL21479711 0.79 KDM4E (0.68) CYP19A1TP53MAPTATP4AATP4B
SCHEMBL2307283 0.78 CYP2E1 (0.47) TP53MAPTATP4AATP4BKDM4E
SCHEMBL28817509 0.78 GFER (0.53) CYP19A1MAPTKDM4EMEN1KMT2A
SCHEMBL5396498 0.78 RAB9A (0.50) CYP19A1MAPTKDM4EMEN1KMT2A
SCHEMBL2096509 0.77 TP53 (0.52) TP53MAPTKDM4ELMNA
SCHEMBL2096508 0.77 PIM1 (0.52) TP53MAPTATP4AATP4BKDM4E
SCHEMBL21479710 0.76 KDM4E (0.68) CYP19A1ATP4AATP4BKDM4EMEN1
SCHEMBL28482008 0.76 TLR7 (0.46) TP53MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583218-A Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation BRISTOL MYERS SQUIBB CO 2015-04-29 CN disclosed